PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Raj Murthi, S.* ; Petry, A.* ; Shashikadze, B.* ; Stöckl, J.B.* ; Schmid, M.* ; Santamaria, G.* ; Klingel, K.* ; Kračun, D.* ; Chen, X.* ; Bauer, S.* ; Schmitt, J.P.* ; Flenkenthaler, F.* ; Gorham, J.M.* ; Toepfer, C.N.* ; Potěšil, D.* ; Hruška, P.* ; Zdráhal, Z.* ; Mayer, Z.* ; Klop, M.* ; Lehmann, L.* ; Qin, Y.* ; Papanakli, L.* ; Spielmann, N. ; Moretti, A.* ; Fröhlich, T.* ; Ewert, P.* ; Holdenrieder, S.* ; Seidman, J.G.* ; Seidman, C.E.* ; Görlach, A.* ; Wolf, C.M.*

Contribution of hypoxia-inducible factor 1alpha to pathogenesis of sarcomeric hypertrophic cardiomyopathy.

Sci. Rep. 15:2132 (2025)
Verlagsversion DOI PMC
Open Access Gold
Creative Commons Lizenzvertrag
Hypertrophic cardiomyopathy (HCM) caused by autosomal-dominant mutations in genes coding for structural sarcomeric proteins, is the most common inherited heart disease. HCM is associated with myocardial hypertrophy, fibrosis and ventricular dysfunction. Hypoxia-inducible transcription factor-1α (Hif-1α) is the central master regulators of cellular hypoxia response and associated with HCM. Yet its exact role remains to be elucidated. Therefore, the effect of a cardiomyocyte-specific Hif-1a knockout (cHif1aKO) was studied in an established α-MHC719/+ HCM mouse model that exhibits the classical features of human HCM. The results show that Hif-1α protein and HIF targets were upregulated in left ventricular tissue of α-MHC719/+ mice. Cardiomyocyte-specific abolishment of Hif-1a blunted the disease phenotype, as evidenced by decreased left ventricular wall thickness, reduced myocardial fibrosis, disordered SRX/DRX state and ROS production. cHif1aKO induced normalization of pro-hypertrophic and pro-fibrotic left ventricular remodeling signaling evidenced on whole transcriptome and proteomics analysis in α-MHC719/+ mice. Proteomics of serum samples from patients with early onset HCM revealed significant modulation of HIF. These results demonstrate that HIF signaling is involved in mouse and human HCM pathogenesis. Cardiomyocyte-specific knockout of Hif-1a attenuates disease phenotype in the mouse model. Targeting Hif-1α might serve as a therapeutic option to mitigate HCM disease progression.
Impact Factor
Scopus SNIP
Altmetric
3.900
0.000
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Hif1a ; Hypertrophic Cardiomyopathy ; Hypertrophy ; Hypoxia ; Myocardial Fibrosis; Cardiac Myosin; Oxidative Stress; Gene-mutations; Heart-failure; Sudden-death; Mouse Model; Factor-i; Expression; Pathway; Dysfunction
Sprache englisch
Veröffentlichungsjahr 2025
HGF-Berichtsjahr 2025
ISSN (print) / ISBN 2045-2322
e-ISSN 2045-2322
Zeitschrift Scientific Reports
Quellenangaben Band: 15, Heft: 1, Seiten: , Artikelnummer: 2132 Supplement: ,
Verlag Nature Publishing Group
Verlagsort London
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Experimental Genetics (IEG)
POF Topic(s) 30201 - Metabolic Health
Forschungsfeld(er) Genetics and Epidemiology
PSP-Element(e) G-500692-001
Förderungen Projekt DEAL
European Regional Development Fund-Project
CEITEC Proteomics Core Facility, "e-Infrastruktura CZ"-e-INFRA
Instruct-CZ Centre of Instruct-ERIC EU
MEYS CR
German Research Foundation-Transregio Research
European Research Council-ERCAd Grant
DZHK
Stiftung Kinderherz
Forderverein des Deutschen Herzzentrums
Else-Kroner Fresenius Stiftung
DOI 10.1038/s41598-025-85187-9
WOS ID 001401672000032
Scopus ID 85216055529
PubMed ID 39820339
Erfassungsdatum 2025-03-17
[➜Korrektur melden]